Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.040
+0.030 (1.00%)
At close: Nov 4, 2024, 4:00 PM
3.060
+0.020 (0.66%)
Pre-market: Nov 5, 2024, 8:21 AM EST

Trevi Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
22186116204467
Upgrade
Market Cap Growth
46.20%-26.01%472.04%-54.55%-33.49%-
Upgrade
Enterprise Value
152-21654
Upgrade
Last Close Price
3.041.341.930.782.423.75
Upgrade
PE Ratio
--4.57-4.27-0.53-1.33-1.64
Upgrade
PB Ratio
3.331.041.081.181.631.23
Upgrade
P/FCF Ratio
-6.39-2.69-4.08-0.70-1.53-2.89
Upgrade
P/OCF Ratio
-6.40-2.70-4.10-0.70-1.53-2.90
Upgrade
EV/EBITDA Ratio
-3.220.06-0.03-0.17-0.16-0.14
Upgrade
EV/EBIT Ratio
-3.200.06-0.03-0.17-0.16-0.14
Upgrade
EV/FCF Ratio
-4.210.06-0.03-0.19-0.18-0.16
Upgrade
Debt / Equity Ratio
0.020.020.090.860.520.01
Upgrade
Debt / FCF Ratio
-0.04-0.04-0.32-0.51-0.49-0.02
Upgrade
Quick Ratio
10.2914.258.992.898.1011.13
Upgrade
Current Ratio
10.6815.039.152.988.3311.45
Upgrade
Return on Equity (ROE)
-48.09%-30.59%-46.82%-153.03%-80.07%-85.70%
Upgrade
Return on Assets (ROA)
-30.88%-19.96%-23.15%-47.42%-37.91%-47.22%
Upgrade
Return on Capital (ROIC)
-32.92%-21.15%-25.18%-55.37%-42.13%-53.47%
Upgrade
Earnings Yield
-17.57%-33.97%-25.21%-167.88%-73.64%-38.95%
Upgrade
FCF Yield
-14.89%-37.22%-24.50%-143.18%-65.27%-34.54%
Upgrade
Buyback Yield / Dilution
-9.43%-53.44%-182.56%-26.48%-53.88%-2581.79%
Upgrade
Total Shareholder Return
-9.43%-53.44%-182.56%-26.48%-53.88%-2581.79%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.